Skip to main content
Top
Published in: Rheumatology International 6/2009

01-04-2009 | Case Report

Dengue fever and Kawasaki disease: a clinical dilemma

Authors: Surjit Singh, Kana Ram Jat, Deepti Suri, R. K. Ratho

Published in: Rheumatology International | Issue 6/2009

Login to get access

Abstract

There are several pediatric conditions which can present with fever and rash; however, it is uncommon to have two diseases occurring in a patient at the same time. We report a young child with fever and rash. He was initially diagnosed to have dengue fever based on clinical features and serological tests. Later in the course of illness he developed findings consistent with Kawasaki disease. This is extremely unusual and has rarely been reported before.
Literature
1.
go back to reference Rundel RP, Petty RE (2005) Kawasaki disease. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier Saunders, Philadelphia, pp 521–538 Rundel RP, Petty RE (2005) Kawasaki disease. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier Saunders, Philadelphia, pp 521–538
2.
go back to reference Newburger JW, Takahashi M, Gerber MA, Gewitz MH et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733PubMedCrossRef Newburger JW, Takahashi M, Gerber MA, Gewitz MH et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733PubMedCrossRef
3.
go back to reference Sopontammarak S, Pruekprasert P (2000) Concomitant dengue hemorrhagic fever with Kawasaki disease. Southeast Asian J Trop Med Public Health 31:190–192PubMed Sopontammarak S, Pruekprasert P (2000) Concomitant dengue hemorrhagic fever with Kawasaki disease. Southeast Asian J Trop Med Public Health 31:190–192PubMed
4.
go back to reference Tourneux P, Dufillot D, Boussemart T, Belloy M (2002) Kawasaki disease and dengue: a fortuitous association? Arch Pediatr 9:218PubMedCrossRef Tourneux P, Dufillot D, Boussemart T, Belloy M (2002) Kawasaki disease and dengue: a fortuitous association? Arch Pediatr 9:218PubMedCrossRef
5.
go back to reference Mekmullica J, Pancharoen C, Deerojanawong J, Lertsapcharoen P (2005) Concomitant dengue infection and Kawasaki disease in an infant: a case report and literature review. J Med Assoc Thai 88:436–439PubMed Mekmullica J, Pancharoen C, Deerojanawong J, Lertsapcharoen P (2005) Concomitant dengue infection and Kawasaki disease in an infant: a case report and literature review. J Med Assoc Thai 88:436–439PubMed
6.
go back to reference Kuijpers TW, Herweijer TJ, Scholvinck L, Wertheim-Van Dillen PM, Van de Verr EMA (2000) Kawasaki disease associated with measles virus infection in a mono-zygotic twin. Pediatr Infect Dis J 19:350–353PubMedCrossRef Kuijpers TW, Herweijer TJ, Scholvinck L, Wertheim-Van Dillen PM, Van de Verr EMA (2000) Kawasaki disease associated with measles virus infection in a mono-zygotic twin. Pediatr Infect Dis J 19:350–353PubMedCrossRef
7.
go back to reference Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A et al (1988) Epstein-Barr virus genome-positive T-lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333:455–457PubMedCrossRef Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A et al (1988) Epstein-Barr virus genome-positive T-lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333:455–457PubMedCrossRef
8.
go back to reference Davies HD, Kirk V, Jadavji T, Kotzin BL (1996) Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr Infect Dis J 15:1136–1138PubMedCrossRef Davies HD, Kirk V, Jadavji T, Kotzin BL (1996) Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr Infect Dis J 15:1136–1138PubMedCrossRef
9.
go back to reference Hoare S, Abinun M, Cant AJ (1997) Overlap between Kawasaki disease and group a streptococcal infection. Pediatr Infect Dis J 16:633–634PubMedCrossRef Hoare S, Abinun M, Cant AJ (1997) Overlap between Kawasaki disease and group a streptococcal infection. Pediatr Infect Dis J 16:633–634PubMedCrossRef
10.
go back to reference Kuijpers TW, Tjia KL, de Jager F, Peters M, Lam J (1998) A boy with chickenpox whose fingers peeled. Lancet 351:1782PubMedCrossRef Kuijpers TW, Tjia KL, de Jager F, Peters M, Lam J (1998) A boy with chickenpox whose fingers peeled. Lancet 351:1782PubMedCrossRef
11.
go back to reference World Health Organization (1997) Dengue haemorrhagic fever diagnosis, treatment, prevention and control, 2nd edn. World Health Organization, Geneva World Health Organization (1997) Dengue haemorrhagic fever diagnosis, treatment, prevention and control, 2nd edn. World Health Organization, Geneva
12.
13.
go back to reference Hara T, Mizuno Y, Akeda H, Fukushige J et al (1988) Thrombocytopenia: a complication of Kawasaki disease. Eur J Pediatr 147:51–53PubMedCrossRef Hara T, Mizuno Y, Akeda H, Fukushige J et al (1988) Thrombocytopenia: a complication of Kawasaki disease. Eur J Pediatr 147:51–53PubMedCrossRef
Metadata
Title
Dengue fever and Kawasaki disease: a clinical dilemma
Authors
Surjit Singh
Kana Ram Jat
Deepti Suri
R. K. Ratho
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0769-3

Other articles of this Issue 6/2009

Rheumatology International 6/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.